BCAS4

Chr 20

breast carcinoma amplified sequence 4

Also known as: CNOL

The BCAS4 protein is predicted to be part of the BLOC-1 complex in the cytoplasm, which is involved in biogenesis of lysosome-related organelles. Mutations in BCAS4 cause Hermansky-Pudlak syndrome type 9, an autosomal recessive disorder characterized by oculocutaneous albinism, bleeding diathesis due to platelet storage pool deficiency, and variable pulmonary fibrosis. The gene shows low constraint to loss-of-function variants, consistent with the recessive inheritance pattern.

Summary from RefSeq
Research Assistant →
0
Active trials
0
Pubs (1 yr)
14
P/LP submissions
0%
P/LP missense
1.56
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryBCAS4
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
14 unique Pathogenic / Likely Pathogenic· 36 VUS of 68 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.56LOEUF
pLI 0.000
Z-score 0.41
OE 0.84 (0.481.56)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.38Z-score
OE missense 0.90 (0.761.06)
102 obs / 113.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.84 (0.481.56)
00.351.4
Missense OE0.90 (0.761.06)
00.61.4
Synonymous OE0.96
01.21.6
LoF obs/exp: 7 / 8.3Missense obs/exp: 102 / 113.5Syn Z: 0.24
DN
0.6162th %ile
GOF
0.74top 25%
LOF
0.3065th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

68 submitted variants in ClinVar

Classification Summary

Pathogenic10
Likely Pathogenic4
VUS36
Likely Benign10
Benign2
10
Pathogenic
4
Likely Pathogenic
36
VUS
10
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
10
0
10
Likely Pathogenic
0
0
4
0
4
VUS
0
35
1
0
36
Likely Benign
0
6
1
3
10
Benign
0
1
1
0
2
Total04217362

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

BCAS4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →